By Tom McParland | August 19, 2020
U.S. District Judge Denise L. Cote of the Southern District of New York said Tuesday there was reason to believe that alleged scheme at Shkreli's Vyera Pharmaceuticals was still occurring, more than five years after the price of the company's branded drug increased overnight to $750 per pill.
By C. Ryan Barber | August 17, 2020
"Wherever the limits of the government's power lie, this case is not close to them," wrote Judge David Hamilton, who was joined on the panel by Judges Ilana Rovner and Michael Scudder.
By Scott Graham | June 8, 2020
The company's agreement to trade biosimilar competitors' earlier market entry in Europe for lengthier exclusivity in the U.S. does not run afoul of the Supreme Court's Actavis decision, U.S. District Judge Manish Shah ruled Monday.
By Mike Scarcella | April 30, 2020
"Notwithstanding this dispute, Gilead will continue to work with federal agencies, including HHS and the CDC," Gilead, represented by a team from Wilmer Cutler Pickering Hale and Dorr, including former U.S. Attorney Ronald Machen Jr., said in announcing the new lawsuit.
By MP McQueen | March 20, 2020
As health officials warn of a shortage of personal protective equipment and ventilators in the COVID-19 pandemic, President Donald Trump invoked the Defense Production Act of 1950 and issued an executive order empowering the federal government to allocate manufacturers' output to the federal government, citing a national security emergency. What does this mean for general counsel of medical suppliers, or companies that could produce medical supplies?
By Amanda Bronstad | February 25, 2020
Mallinckrodt's "settlement framework" resolves thousands of claims brought by cities and counties in the multidistrict litigation and has the support of 47 attorneys general from states and U.S. territories.
By Scott Graham | February 5, 2020
The Patent Trial and Appeal Board turned away the first two of four challenges Gilead is bringing against the United States, which says it was the first to patent the use of Truvada to prevent HIV infections.
By Mike Scarcella | February 5, 2020
Novo Nordisk, represented by lawyers from Morgan, Lewis & Bockius, is locked in a dispute with BioMarin Pharmaceutical, represented by Jones Day, in courts in Massachusetts, Texas, New York and California. A Boston judge on Wednesday declined to issue a temporary restraining order.
By Tom McParland | January 27, 2020
In her lawsuit, James said that Daraprim, which is also used to treat HIV, had been "cheap and accessible" for decades, until Turing purchased the drug and then dramatically raised its price overnight
By Scott Graham | January 21, 2020
The former co-chair of Williams & Connolly's patent litigation practice has counted Eli Lilly and Bayer among his clients. Latham leaders say his arrival will cement the firm's transition to the brand side of Hatch-Waxman litigation.
Presented by BigVoodoo
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
With bold growth in recent years, Fox Rothschild brings together 1,000 attorneys coast to coast. We offer the reach and resources of a natio...
About Us:Monjur.com is a leading provider of contracts-as-a-service for managed service providers, offering tailored solutions to streamline...
Dynamic Boutique law firm with offices in NYC, Westchester County and Dutchess County, is seeking a mid level litigation associate to work ...